Korelasi Hasil Pemeriksaan Laboratorium dan Diagnostik pada Pasien Diabetes Mellitus
DOI:
https://doi.org/10.36565/jab.v11i2.445Keywords:
ECG and LDL levels, laboratory results and diabetes diagnosisAbstract
Diabetes Mellitus (DM) is a serious obstacle in health causing death, disease severity, due to the process of oxidative reactions producing free radicals that damage tissues, which are complications of the disease. Complications are micro and macrovascular in the liver and heart which are characterized by increased results of laboratory and diagnostic tests in DM patients during the pandemic. The purpose of the study was to determine the correlation between laboratory and diagnostic results in DM patients. The research method uses a correlation design with a cross-sectional approach using secondary data in the form of medical records from March-December 2020, a sample of 25 DM patients who underwent SGOT, SGPT, LDL, and ECG tests were statistically tested with chi-square. The results showed that there was no correlation with laboratory results (LDL, EKG) At most 56% fasting blood sugar was abnormal with abnormal LDL, there was no correlation between laboratory and diagnostic results (LDL) in DM patients with p value = (0.2). There is no correlation between laboratory and diagnostic results (ECG) in DM patients with p value = (0.54). At most 52% fasting blood sugar was abnormal with abnormal ECG, no correlation of laboratory and diagnostic results (ECG) in DM patients with p value = (1,0)References
Alwafi, H., Wei, L., Naser, A. Y., Mongkhon, P., Tse, G., Man, K. K. C., Bell, J. S., Ilomaki, J., Fang, G., & Wong, I. C. K. (2020). Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK. BMJ Open, 10(5), e034573.
Association, A. D. (2021). 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S15–S33.
Costell, M. H., Ancellin, N., Bernard, R. E., Zhao, S., Upson, J. J., Morgan, L. A., Hauk, K., Olzinski, A. R., Ballard, V. L. T., & Herry, K. (2012). Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. Frontiers in Pharmacology, 3, 128.
Fung, A. C. H., Tse, G., Cheng, H. L., Lau, E. S. H., Luk, A., Ozaki, R., So, T. T. Y., Wong, R. Y. M., Tsoh, J., & Chow, E. (2018). Depressive symptoms, co-morbidities, and glycemic control in Hong Kong Chinese elderly patients with type 2 diabetes mellitus. Frontiers in Endocrinology, 9, 261.
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., & Ogurtsova, K. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice, 157, 107843.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
